Healthcare Realty Trust (HR) Earnings Date & Reports

Key Takeaways

• Healthcare Realty Trust (NYSE: HR) reported normalized funds from operations (FFO, a key earnings measure for real estate investment trusts) of $0.42 per share, topping the consensus estimate of $0.41.
• Total revenue came in at $286.64 million, beating analyst expectations by roughly $3.19 million.
• Management raised its full-year 2026 normalized FFO guidance to a range of $1.65 to $1.67 per share.
• Same-store cash net operating income (NOI, income generated from property operations) grew 5.1%, supported by cash leasing spreads of 8.6%.
• GAAP (generally accepted accounting principles) net loss narrowed to $0.05 per share, down from $0.17 per share a year earlier.
• The board maintained its quarterly dividend of $0.24 per share.
• For more details on HR's Major News, Today's Price Move, Price Targets, and Forecast, be sure to explore these dedicated pages.
• Investors looking for additional data-driven ideas can also explore Trending AI Robots.

Earnings Context and Why It Matters

Healthcare Realty Trust is the largest publicly traded, pure-play owner and operator of medical outpatient buildings (MOBs) in the United States, a segment benefiting as healthcare delivery shifts away from hospitals toward lower-cost outpatient settings. This quarterly report is a key checkpoint on the company's "Healthcare Realty 2.0" strategic plan, which emphasizes portfolio optimization, stronger lease economics, and disciplined capital allocation. The third quarter of 2026 shows whether the turnaround's operating momentum—marked by record leasing, improving occupancy, and rising same-store NOI—can continue, and whether management's guidance increases are translating into durable per-share earnings growth.

Reported Results

For the third quarter ended September 30, 2026, Healthcare Realty reported normalized FFO of $0.42 per diluted share, edging past the $0.41 consensus estimate and matching the prior-year figure of $0.41. NAREIT (National Association of Real Estate Investment Trusts) FFO rose to $0.38 per share from $0.34 a year ago. Total revenue of $286.64 million surpassed expectations by about $3.19 million, though it declined from $297.77 million in the prior-year quarter as ongoing property dispositions reduced the top line.

Operationally, same-store cash NOI increased 5.1%, tenant retention held at 88.0%, and average cash leasing spreads reached 8.6%. The company executed 1.5 million square feet of new and renewal leases. GAAP net loss attributable to common stockholders narrowed to $15.8 million, or $0.05 per share, a meaningful improvement from a loss of $57.7 million, or $0.17 per share, a year earlier.

Management raised 2026 normalized FFO guidance to $1.65–$1.67 per share (from $1.62–$1.66), lifted NAREIT FFO guidance to $1.48–$1.52 per share, and increased same-store cash NOI growth guidance to 5.00%–5.25% (from 4.25%–5.00%).

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, and breakout candidates far more efficiently than manual screening. For investors tracking healthcare real estate and other sectors, it offers a practical way to monitor opportunities alongside earnings-driven analysis.

Market Reaction and Investor Sentiment

Healthcare Realty shares rose more than 3% in the session following the release, reflecting investor approval of the FFO beat and the upwardly revised guidance. Sentiment around the stock has been improving through 2026 as the company's operational turnaround gains traction, with several sell-side analysts raising price targets earlier in the year. The combination of a modest earnings beat, a second consecutive guidance increase, and continued share repurchases reinforces the view that management's strategic plan is producing measurable results.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should watch whether the company can sustain its same-store NOI growth near the low-single-digit-to-mid-single-digit range while executing on its portfolio optimization. The raised full-year guidance now implies solid momentum through the fourth quarter, but execution risk remains around signed-but-not-occupied leases converting into rent-paying occupancy.

Capital allocation will remain a central theme. Healthcare Realty repurchased 4.2 million shares during the quarter and early October at an average price of $17.74, and it renewed its $500 million buyback authorization. Ongoing dispositions, refinancing activity, and acquisitions within its joint venture with KKR will shape both the balance sheet and per-share earnings.

Finally, investors should monitor leverage and interest-rate sensitivity. Net debt to adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) stood at 5.5x, and the company carries substantial near-term liquidity of roughly $1.6 billion. How management balances growth, buybacks, and debt reduction will be an important driver of future results and investor confidence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations